{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:08:03Z","timestamp":1772723283783,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["255778"],"award-info":[{"award-number":["255778"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN205717"],"award-info":[{"award-number":["IN205717"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present investigation using Positron Emission Tomography shows how peptide VSAK can reduce the detrimental effects produced by lipopolysaccharides in Dutch dwarf rabbits, used to develop the Systemic Inflammatory Response Syndrome (SIRS). Animals concomitantly treated with lipopolysaccharides (LPS) and peptide VSAK show important protection in the loss of radiolabeled-glucose uptake observed in diverse organs when animals are exclusively treated with LPS. Treatment with peptide VSAK prevented the onset of changes in serum levels of glucose and insulin associated with the establishment of SIRS and the insulin resistance-like syndrome. Treatment with peptide VSAK also allowed an important attenuation in the circulating levels of pro-inflammatory molecules in LPS-treated animals. As a whole, our data suggest that peptide VSAK might be considered as a candidate in the development of new therapeutic possibilities focused on mitigating the harmful effects produced by lipopolysaccharides during the course of SIRS.<\/jats:p>","DOI":"10.1038\/s41598-021-94224-2","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T10:26:57Z","timestamp":1626776817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study"],"prefix":"10.1038","volume":"11","author":[{"given":"Ismael","family":"Luna-Reyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Er\u00e9ndira G.","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Delgado-Coello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"\u00c1vila-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Mas-Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"94224_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet 392, 75\u201387 (2018).","journal-title":"Lancet"},{"key":"94224_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315, 801 (2016).","journal-title":"JAMA"},{"key":"94224_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369, 840\u2013851 (2013).","journal-title":"N. Engl. J. Med."},{"key":"94224_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.arcmed.2004.07.006","volume":"35","author":"LN L\u00f3pez-Boj\u00f3rquez","year":"2004","unstructured":"L\u00f3pez-Boj\u00f3rquez, L. N., Dehesa, A. Z. & Reyes-Ter\u00e1n, G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Medical Res. 35, 465\u2013479 (2004).","journal-title":"Arch. Medical Res."},{"key":"94224_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano, M. J. & Ward, P. A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?. J. Clin. Invest. 126, 23\u201331 (2016).","journal-title":"J. Clin. Invest."},{"key":"94224_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40635-018-0189-y","volume":"6","author":"MF Osuchowski","year":"2018","unstructured":"Osuchowski, M. F. et al. Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis. Int. Care Med. Exp. 6, 26 (2018).","journal-title":"Int. Care Med. Exp."},{"key":"94224_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/SHK.0b013e318277109c","volume":"39","author":"LF Gentile","year":"2013","unstructured":"Gentile, L. F. & Moldawer, L. L. DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis. Shock 39, 113\u2013114 (2013).","journal-title":"Shock"},{"key":"94224_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/SHK.0b013e318157ee55","volume":"29","author":"H Tsujimoto","year":"2008","unstructured":"Tsujimoto, H. et al. Role of toll-like receptors in the development of sepsis. Shock 29, 315\u2013321 (2008).","journal-title":"Shock"},{"key":"94224_CR9","doi-asserted-by":"crossref","unstructured":"Jackson, J. J. & Kropp, H. \u00df-Lactam Antibiotic-Induced Release of Free Endotoxin: In Vitro Comparison of Penicillin-Binding Protein (PBP) 2-Specific Imipenem and PBP 3-Specific Ceftazidime. J. Infect. Dis. 165, 1033\u20131041 (1992).","DOI":"10.1093\/infdis\/165.6.1033"},{"key":"94224_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijmm.2007.04.001","volume":"297","author":"R Jerala","year":"2007","unstructured":"Jerala, R. Structural biology of the LPS recognition. Int. J. Med. Microbiol. 297, 353\u2013363 (2007).","journal-title":"Int. J. Med. Microbiol."},{"key":"94224_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nri2402","volume":"8","author":"D Rittirsch","year":"2008","unstructured":"Rittirsch, D., Flierl, M. A. & Ward, P. A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776\u2013787 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"94224_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1004","volume":"3","author":"B Beutler","year":"2003","unstructured":"Beutler, B. & Rietschel, E. T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169\u2013176 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"94224_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.bpj.2011.04.041","volume":"100","author":"Y Kaconis","year":"2011","unstructured":"Kaconis, Y. et al. Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys. J. 100, 2652\u20132661 (2011).","journal-title":"Biophys. J."},{"key":"94224_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/hmg\/11.8.937","volume":"11","author":"CD Bingle","year":"2002","unstructured":"Bingle, C. D. & Craven, C. J. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11, 937\u2013943 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"94224_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.it.2003.11.007","volume":"25","author":"CD Bingle","year":"2004","unstructured":"Bingle, C. D. & Craven, C. J. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol. 25, 53\u201355 (2004).","journal-title":"Trends Immunol."},{"key":"94224_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1570-9639(04)00003-2","volume":"1699","author":"B Ghafouri","year":"2004","unstructured":"Ghafouri, B., Kihlstr\u00f6m, E., Tagesson, C. & Lindahl, M. PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim. Biophys. Acta Proteins Proteomics 1699, 57\u201363 (2004).","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"94224_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1022832531473","volume":"245","author":"AL Alonso-Garcia","year":"2003","unstructured":"Alonso-Garcia, A. L., Zentella-Dehesa, A. & Mas-Oliva, J. Characterization of a naturally occurring new version of the cholesterol ester transfer protein (CETP) from small intestine. Mol. Cell. Biochem. 245, 173\u2013182 (2003).","journal-title":"Mol. Cell. Biochem."},{"key":"94224_CR18","doi-asserted-by":"publisher","first-page":"16091","DOI":"10.1038\/srep16091","volume":"5","author":"V Garc\u00eda-Gonz\u00e1lez","year":"2015","unstructured":"Garc\u00eda-Gonz\u00e1lez, V., Guti\u00e9rrez-Quintanar, N. & Mas-Oliva, J. The C-terminal domain supports a novel function for CETPI as a new plasma lipopolysaccharide-binding protein. Sci. Rep. 5, 16091 (2015).","journal-title":"Sci. Rep."},{"key":"94224_CR19","first-page":"1","volume":"6","author":"I Luna-Reyes","year":"2018","unstructured":"Luna-Reyes, I., P\u00e9rez-Hern\u00e1ndez, E., \u00c1vila-Rodr\u00edguez, M. \u00c1. & Mas-Oliva, J. P38 the process of septic shock is attenuated by the intravenous administration of peptide VSAK: A FDG-PET study, sepsis 2018. Intensive Care Med. Exp. 6, 1\u201333 (2018).","journal-title":"Intensive Care Med. Exp."},{"key":"94224_CR20","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.276.5320.1861","volume":"276","author":"LJ Beamer","year":"1997","unstructured":"Beamer, L. J., Carroll, S. F. & Eisenberg, D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276, 1861\u20134 (1997).","journal-title":"Science"},{"key":"94224_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nsmb1197","volume":"14","author":"X Qiu","year":"2007","unstructured":"Qiu, X. et al. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat. Struct. Mol. Biol. 14, 106\u2013113 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"94224_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.immuni.2013.09.005","volume":"39","author":"JK Eckert","year":"2013","unstructured":"Eckert, J. K. et al. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity 39, 647\u2013660 (2013).","journal-title":"Immunity"},{"key":"94224_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsb.2014.02.002","volume":"186","author":"V Garc\u00eda-Gonz\u00e1lez","year":"2014","unstructured":"Garc\u00eda-Gonz\u00e1lez, V. et al. Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity. J. Struct. Biol. 186, 19\u201327 (2014).","journal-title":"J. Struct. Biol."},{"key":"94224_CR24","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1128\/AAC.00531-12","volume":"56","author":"LE Via","year":"2012","unstructured":"Via, L. E. et al. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56, 4391\u20134402 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"94224_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/17453674.2014.900894","volume":"85","author":"JCE Odekerken","year":"2014","unstructured":"Odekerken, J. C. E. et al. (18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: a longitudinal study of an implant osteomyelitis in the rabbit tibia. Acta Orthop. 85, 305\u2013313 (2014).","journal-title":"Acta Orthop."},{"key":"94224_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-4804(80)90037-2","volume":"29","author":"KA Wichterman","year":"1980","unstructured":"Wichterman, K. A., Baue, A. E. & Chaudry, I. H. Sepsis and septic shock\u2014a review of laboratory models and a proposal. J. Surg. Res. 29, 189\u2013201 (1980).","journal-title":"J. Surg. Res."},{"key":"94224_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SHK.0b013e318181a343","volume":"30","author":"LF Poli-de-Figueiredo","year":"2008","unstructured":"Poli-de-Figueiredo, L. F., Garrido, A. G., Nakagawa, N. & Sannomiya, P. Experimental models of sepsis and their clinical relevance. Shock 30, 53\u201359 (2008).","journal-title":"Shock"},{"key":"94224_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4161\/viru.26083","volume":"5","author":"MP Fink","year":"2014","unstructured":"Fink, M. P. Animal models of sepsis.  Virulence 5, 143\u2013153 (2014).","journal-title":"Virulence"},{"key":"94224_CR29","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2010.509","volume":"79","author":"A Mather","year":"2011","unstructured":"Mather, A. & Pollock, C. Glucose handling by the kidney. Kidney Int. 79, S1\u2013S6 (2011).","journal-title":"Kidney Int."},{"key":"94224_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0002-9610(78)90040-5","volume":"135","author":"GHA Clowes","year":"1978","unstructured":"Clowes, G. H. A. et al. Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am. J. Surg. 135, 577\u2013583 (1978).","journal-title":"Am. J. Surg."},{"key":"94224_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/00005373-198408000-00002","volume":"24","author":"MG Clemens","year":"1984","unstructured":"Clemens, M. G., Chaudry, I. H., Daigneau, N. & Baue, A. E. Insulin resistance and depressed gluconeogenic capability during early hyperglycemic sepsis. J. Trauma 24, 701\u2013708 (1984).","journal-title":"J. Trauma"},{"key":"94224_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/bjs.4081","volume":"90","author":"GL Carlson","year":"2003","unstructured":"Carlson, G. L. Insulin resistance in sepsis. Br. J. Surg. 90, 259\u2013260 (2003).","journal-title":"Br. J. Surg."},{"key":"94224_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00134-004-2167-y","volume":"30","author":"PE Marik","year":"2004","unstructured":"Marik, P. E. & Raghavan, M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 30, 748\u2013756 (2004).","journal-title":"Intensive Care Med."},{"key":"94224_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1681\/ASN.2006101091","volume":"19","author":"M Schetz","year":"2008","unstructured":"Schetz, M. et al. Tight blood glucose control is renoprotective in critically ill patients. J. Am. Soc. Nephrol. 19, 571 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94224_CR35","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2337\/dc10-2197","volume":"34","author":"MI Lassenius","year":"2011","unstructured":"Lassenius, M. I. et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34, 1809\u20131815 (2011).","journal-title":"Diabetes Care"},{"key":"94224_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db09-0367","volume":"59","author":"NN Mehta","year":"2010","unstructured":"Mehta, N. N. et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59, 172\u2013181 (2010).","journal-title":"Diabetes"},{"key":"94224_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13813450802181047","volume":"114","author":"I Nieto-Vazquez","year":"2008","unstructured":"Nieto-Vazquez, I. et al. Insulin resistance associated to obesity: the link TNF-alpha. Arch. Physiol. Biochem. 114, 183\u2013194 (2008).","journal-title":"Arch. Physiol. Biochem."},{"key":"94224_CR38","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s001340051237","volume":"26","author":"PE Marik","year":"2000","unstructured":"Marik, P. E. & Zaloga, G. P. Hypothermia and cytokines in septic shock. Intensive Care Med. 26, 716\u2013721 (2000).","journal-title":"Intensive Care Med."},{"key":"94224_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2344\/0003-3006-57.1.25","volume":"57","author":"M D\u00edaz","year":"2010","unstructured":"D\u00edaz, M. & Becker, D. E. Thermoregulation: physiological and clinical considerations during sedation and general anesthesia. Anesth. Prog. 57, 25 (2010).","journal-title":"Anesth. Prog."},{"key":"94224_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccm.2008.06.003","volume":"29","author":"M Singer","year":"2008","unstructured":"Singer, M. Cellular dysfunction in sepsis. Clin. Chest Med. 29, 655\u2013660 (2008).","journal-title":"Clin. Chest Med."},{"key":"94224_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","volume":"5","author":"M Singer","year":"2014","unstructured":"Singer, M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5, 66\u201372 (2014).","journal-title":"Virulence"},{"key":"94224_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2197-425X-2-19","volume":"2","author":"JA Vogt","year":"2014","unstructured":"Vogt, J. A. et al. Effects of glycemic control on glucose utilization and mitochondrial respiration during resuscitated murine septic shock. Intensive Care Med. Exp. 2, 19 (2014).","journal-title":"Intensive Care Med. Exp."},{"key":"94224_CR43","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/01.PCC.0000161284.96739.3A","volume":"6","author":"RG Branco","year":"2015","unstructured":"Branco, R. G. et al. Glucose level and risk of mortality in pediatric septic shock. Ped. Crit. Care Med. 6, 470\u2013472 (2015).","journal-title":"Ped. Crit. Care Med."},{"key":"94224_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"Y-C Lu","year":"2008","unstructured":"Lu, Y.-C., Yeh, W.-C. & Ohashi, P. S. LPS\/TLR4 signal transduction pathway. Cytokine 42, 145\u2013151 (2008).","journal-title":"Cytokine"},{"key":"94224_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-7-1","volume":"7","author":"L Hoareau","year":"2010","unstructured":"Hoareau, L. et al. Signaling pathways involved in LPS induced TNFalpha production in human adipocytes. J. Inflamm. (Lond.) 7, 1 (2010).","journal-title":"J. Inflamm. (Lond.)"},{"key":"94224_CR46","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi, H. et al. TLR4 links innate immunity and fatty acid\u2013induced insulin resistance. J. Clin. Invest. 116, 3015\u20133025 (2006).","journal-title":"J. Clin. Invest."},{"key":"94224_CR47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","volume":"11","author":"DE Moller","year":"2000","unstructured":"Moller, D. E. Potential role of TNF-\u03b1 in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 11, 212\u2013217 (2000).","journal-title":"Trends Endocrinol. Metab."},{"key":"94224_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/17471060500435662","volume":"2","author":"R Devi Ramnath","year":"2006","unstructured":"Devi Ramnath, R. et al. Inflammatory mediators in sepsis: cytokines, chemokines, adhesion molecules and gases. J. Organ. Dysfunct. 2, 80\u201392 (2006).","journal-title":"J. Organ. Dysfunct."},{"key":"94224_CR49","doi-asserted-by":"publisher","first-page":"8856","DOI":"10.1073\/pnas.97.16.8856","volume":"97","author":"REW Hancock","year":"2000","unstructured":"Hancock, R. E. W. & Scott, M. G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U. S. A. 97, 8856\u20138861 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"94224_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4049\/jimmunol.164.2.549","volume":"164","author":"MG Scott","year":"2000","unstructured":"Scott, M. G., Vreugdenhil, A. C., Buurman, W. A., Hancock, R. E. & Gold, M. R. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164, 549\u2013553 (2000).","journal-title":"J. Immunol."},{"key":"94224_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"K Brown","year":"2006","unstructured":"Brown, K. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157\u2013169 (2006).","journal-title":"Lancet"},{"key":"94224_CR52","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","volume":"24","author":"J Cohen","year":"1996","unstructured":"Cohen, J. & Carlet, J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit. Care Med. 24, 1431\u201340 (1996).","journal-title":"Crit. Care Med."},{"key":"94224_CR53","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581\u2013614 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"94224_CR54","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal, S. M. et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit. Care Med. 25, 1115\u201324 (1997).","journal-title":"Crit. Care Med."},{"key":"94224_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/emm.2017.75","volume":"49","author":"S B\u00e1rcena-Varela","year":"2017","unstructured":"B\u00e1rcena-Varela, S. et al. Coupling killing to neutralization: combined therapy with ceftriaxone\/Pep19\u20132.5 counteracts sepsis in rabbits. Exp. Mol. Med. 49, 345 (2017).","journal-title":"Exp. Mol. Med."},{"key":"94224_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bbamem.2016.01.011","volume":"1858","author":"K Brandenburg","year":"2016","unstructured":"Brandenburg, K., Heinbockel, L., Correa, W. & Lohner, K. Peptides with dual mode of action: killing bacteria and preventing endotoxin-induced sepsis. Biochim. Biophys. Acta Biomembr. 1858, 971\u2013979 (2016).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"94224_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725\u2013738 (2010).","journal-title":"Nat. Protoc."},{"key":"94224_CR58","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"94224_CR59","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1021\/acs.jctc.5b00513","volume":"11","author":"Y Qi","year":"2015","unstructured":"Qi, Y. et al. CHARMM-GUI martini maker for coarse-grained simulations with the martini force field. J. Chem. Theory Comput. 11, 4486\u20134494 (2015).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94224-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94224-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94224-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:46:16Z","timestamp":1670067976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94224-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94224"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94224-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M\u2013O. is inventor on patent application PCT\/MX2014\/00087 related to this study, \u201cPeptides derived from the C-Terminal domain of CETPI as molecules blocking the lipopolysaccharide-induced effect in sepsis and septic shock\u201d, submitted to the World Intellectual Property Organization and held by Universidad Nacional Aut\u00f3noma de M\u00e9xico. I.L-R., E.P\u2013H., B.D-C., and M.A.A-R, declare no competing conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14752"}}